Literature DB >> 12208608

HIV-1 genetic diversity in Western Brittany, France.

Sophie Vallet1, Marie-Christine Legrand-Quillien, Christine Roger, Veronique Bellein, Pascale Perfezou, Luc de Saint-Martin, Michel Garre, Francoise Brun-Vezinet, Bertrand Picard.   

Abstract

We describe human immunodeficiency virus type 1 (HIV-1) diversity in Western Brittany, France, and trace the dissemination of HIV-1 non-B subtype infection. The strategy for HIV-1 subtyping used involved subtype specific enzyme immunoassays, heteroduplex mobility assays and phylogenetic analysis of the sequences of env encoding the V3 loop region. Samples were obtained from 567 patients: 465 (82%) were of subtype B and 66 (11.6%) were not (20 were subtype A, 11 subtype C, four subtype D, seven subtype F, five subtype G and 19 others with circulating recombinant forms: 4CRF01_AE, 11CRF02_AG, 1H, 3CRF11_cpx). These findings are consistent with other studies of French populations. There is an epidemiological correlation between subtype B and homosexual or heterosexual contamination in France and between non-B subtype and heterosexual contamination in Africa. Copyright 2002 Federation of European Microbiological Societies

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208608     DOI: 10.1111/j.1574-695X.2002.tb00604.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  2 in total

1.  Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001.

Authors:  Seema Thakore Meloni; Jean-Louis Sankalé; Donald J Hamel; Geoffrey Eisen; Aissatou Guéye-Ndiaye; Souleymane Mboup; Phyllis J Kanki
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  HIV-1 genetic diversity in antenatal cohort, Canada.

Authors:  Bertine S Akouamba; Janique Viel; Hugues Charest; Natacha Merindol; Johanne Samson; Normand Lapointe; Bluma G Brenner; Richard Lalonde; P Richard Harrigan; Marc Boucher; Hugo Soudeyns
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.